Compare CAVA & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAVA | RGEN |
|---|---|---|
| Founded | 2006 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 6.6B |
| IPO Year | 2023 | 1995 |
| Metric | CAVA | RGEN |
|---|---|---|
| Price | $76.27 | $109.60 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 23 | 12 |
| Target Price | $91.00 | ★ $167.67 |
| AVG Volume (30 Days) | ★ 2.6M | 1.1M |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 286.96 |
| EPS | ★ 0.54 | 0.15 |
| Revenue | ★ $1,179,664,000.00 | $141,236,000.00 |
| Revenue This Year | $25.71 | $14.30 |
| Revenue Next Year | $20.57 | $14.52 |
| P/E Ratio | ★ $143.48 | $759.47 |
| Revenue Growth | 22.41 | ★ 35.10 |
| 52 Week Low | $43.41 | $109.50 |
| 52 Week High | $98.79 | $175.77 |
| Indicator | CAVA | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 32.97 | 37.63 |
| Support Level | $73.72 | N/A |
| Resistance Level | $90.57 | $130.59 |
| Average True Range (ATR) | 3.66 | 5.54 |
| MACD | -2.26 | -0.92 |
| Stochastic Oscillator | 1.71 | 0.67 |
Cava Group Inc owns and operates a chain of restaurants. It operates a Mediterranean-inspired fast-casual restaurant brand offering menu items. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: i) CAVA: It includes the operations of all company-owned CAVA restaurants, and ii) CAVA Foods: It includes the production of dips, spreads, and certain dressing bases used in CAVA restaurants as well as sales from the Company's consumer packaged goods business. The company generates the majority of its revenue from the CAVA segment.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.